Ambulatory Surgical Centers Market to hit USD 144.5 billion by 2032, says Global Market Insights Inc.
09 nov. 2022 05h10 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 09, 2022 (GLOBE NEWSWIRE) -- The ambulatory surgical centers market value is estimated to exceed USD 144.5 billion by 2032, according to a new research report by Global...
NasoNeb is now a Division of Monaghan Medical Corporation
16 juin 2022 10h00 HE
|
NasoNeb, Inc.
PLATTSBURGH, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- NasoNeb®, Inc. is proud to announce their integration with Monaghan Medical Corporation (“Monaghan Medical”) in Plattsburgh, New York. Monaghan...
Otonomy to Host Virtual Investor R&D Event on March 22, 2022
25 févr. 2022 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
25 janv. 2022 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
NasoNeb Welcomes Leading Otolaryngologists to Medical Advisory Board
28 oct. 2021 10h09 HE
|
NasoNeb, Inc.
PLATTSBURGH, N.Y., Oct. 28, 2021 (GLOBE NEWSWIRE) -- NasoNeb, Inc. (the “Company” or “NasoNeb”), a developer of innovative intranasal drug delivery and nasal care solutions, is proud to welcome Dr....
Ambulatory Surgical Centers Market 2021: Top Three Trends Driving the Global Industry Revenue by 2027: Global Market Insights Inc.
04 oct. 2021 06h30 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The ambulatory surgical centers market size is anticipated to record a valuation of USD 117 billion by 2027, according to the most recent...
Otonomy Announces Presentation of OTO-413 Clinical Results at AAO-HNS Annual Meeting
27 sept. 2021 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Otonomy Announces Presentation of OTO-313 Clinical Results at American Neurotology Society Annual Meeting
05 avr. 2021 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
06 févr. 2019 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
Otonomy Announces Multiple Presentations at Society for Neuroscience Annual Meeting including OTO-413 Presentation Selected as "Hot Topic"
30 oct. 2018 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced multiple...